These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


506 related items for PubMed ID: 28138019

  • 1. Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice.
    Mahmoud ME, Fereig R, Nishikawa Y.
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138019
    [Abstract] [Full Text] [Related]

  • 2. Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice.
    Mahmoud ME, Ihara F, Fereig RM, Nishimura M, Nishikawa Y.
    Behav Brain Res; 2016 Feb 01; 298(Pt B):125-33. PubMed ID: 26554725
    [Abstract] [Full Text] [Related]

  • 3. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.
    Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M.
    Infect Immun; 2002 Feb 01; 70(2):779-86. PubMed ID: 11796611
    [Abstract] [Full Text] [Related]

  • 4. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
    Fujigaki S, Takemura M, Hamakawa H, Seishima M, Saito K.
    Adv Exp Med Biol; 2003 Feb 01; 527():97-103. PubMed ID: 15206721
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
    Murakami Y, Hoshi M, Hara A, Takemura M, Arioka Y, Yamamoto Y, Matsunami H, Funato T, Seishima M, Saito K.
    Cytokine; 2012 Aug 01; 59(2):245-51. PubMed ID: 22609210
    [Abstract] [Full Text] [Related]

  • 6. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.
    Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT.
    Infect Immun; 2002 Feb 01; 70(2):859-68. PubMed ID: 11796621
    [Abstract] [Full Text] [Related]

  • 7. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
    Pfaff AW, Mousli M, Sénégas A, Marcellin L, Takikawa O, Klein JP, Candolfi E.
    Int J Parasitol; 2008 Feb 01; 38(2):249-58. PubMed ID: 17822706
    [Abstract] [Full Text] [Related]

  • 8. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
    Ufermann CM, Domröse A, Babel T, Tersteegen A, Cengiz SC, Eller SK, Spekker-Bosker K, Sorg UR, Förster I, Däubener W.
    Front Cell Infect Microbiol; 2019 Feb 01; 9():184. PubMed ID: 31231617
    [Abstract] [Full Text] [Related]

  • 9. Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+ T-Cell Responses, and Premature Mortality.
    Donley DW, Olson AR, Raisbeck MF, Fox JH, Gigley JP.
    PLoS One; 2016 Feb 01; 11(9):e0162404. PubMed ID: 27611938
    [Abstract] [Full Text] [Related]

  • 10. Toxoplasma Effector TgIST Targets Host IDO1 to Antagonize the IFN-γ-Induced Anti-parasitic Response in Human Cells.
    Bando H, Sakaguchi N, Lee Y, Pradipta A, Ma JS, Tanaka S, Lai DH, Liu J, Lun ZR, Nishikawa Y, Sasai M, Yamamoto M.
    Front Immunol; 2018 Feb 01; 9():2073. PubMed ID: 30283439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sialylated N-glycan profile during acute and chronic infections with Toxoplasma gondii in mice.
    Rehan IF, Mahmoud ME, Salman D, Elnagar A, Salman S, Youssef M, Aziz ARA, Bazh EK, Hesham AE.
    Sci Rep; 2020 Mar 02; 10(1):3809. PubMed ID: 32123198
    [Abstract] [Full Text] [Related]

  • 16. Host immune responses to Toxoplasma gondii.
    Sasai M, Pradipta A, Yamamoto M.
    Int Immunol; 2018 Mar 10; 30(3):113-119. PubMed ID: 29408976
    [Abstract] [Full Text] [Related]

  • 17. Toxoplasma Effector GRA15-Dependent Suppression of IFN-γ-Induced Antiparasitic Response in Human Neurons.
    Bando H, Lee Y, Sakaguchi N, Pradipta A, Sakamoto R, Tanaka S, Ma JS, Sasai M, Yamamoto M.
    Front Cell Infect Microbiol; 2019 Mar 10; 9():140. PubMed ID: 31119110
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.
    Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ.
    Infect Immun; 1996 Oct 10; 64(10):4188-96. PubMed ID: 8926087
    [Abstract] [Full Text] [Related]

  • 19. RabGDIα is a negative regulator of interferon-γ-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii.
    Ohshima J, Sasai M, Liu J, Yamashita K, Ma JS, Lee Y, Bando H, Howard JC, Ebisu S, Hayashi M, Takeda K, Standley DM, Frickel EM, Yamamoto M.
    Proc Natl Acad Sci U S A; 2015 Aug 18; 112(33):E4581-90. PubMed ID: 26240314
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory early events associated to the role of P2X7 receptor in acute murine toxoplasmosis.
    Corrêa G, Almeida Lindenberg C, Moreira-Souza AC, Savio LE, Takiya CM, Marques-da-Silva C, Vommaro RC, Coutinho-Silva R.
    Immunobiology; 2017 Apr 18; 222(4):676-683. PubMed ID: 28069296
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.